Abstract:In the process of drug development of RNA-targeting small molecules, elucidating the structural changes upon their interactions with target RNA sequences is desired. We herein provide a detailed in vitro and in-cell selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) protocol to study the RNA structural change in the presence of an experimental drug for spinal muscular atrophy (SMA), survival of motor neuron (SMN)-C2, and in exon 7 of the pre-mRNA of the SMN2 gene. In in vitro SHAPE, an RNA sequence of 140 nucleotides containing SMN2 exon 7 is transcribed by T7 RNA polymerase, folded in the presence of SMN-C2, and subsequently modified by a mild 2'-OH acylation reagent, 2-methylnicotinic acid imidazolide (NAI). This 2'-OH-NAI adduct is further probed by a 32P-labeled primer extension and resolved by polyacrylamide gel electrophoresis (PAGE). Conversely, 2'-OH acylation in in-cell SHAPE takes place in situ with SMN-C2 bound cellular RNA in living cells. The pre-mRNA sequence of exon 7 in the SMN2 gene, along with SHAPE-induced mutations in the primer extension, was then amplified by PCR and subject to next-generation sequencing. Comparing the two methodologies, in vitro SHAPE is a more cost-effective method and does not require computational power to visualize results. However, the in vitro SHAPE-derived RNA model sometimes deviates from the secondary structure in a cellular context, likely due to the loss of all interactions with RNA-binding proteins. In-cell SHAPE does not need a radioactive material workplace and yields a more accurate RNA secondary structure in the cellular context. Furthermore, in-cell SHAPE is usually applicable for a larger range of RNA sequences (~1,000 nucleotides) by utilizing next-generation sequencing, compared to in vitro SHAPE (~200 nucleotides) that usually relies on PAGE analysis. In case of exon 7 in SMN2 pre-mRNA, the in vitro and in-cell SHAPE derived RNA models are similar to each other.

SHAPE Probing to Screen Computationally Designed RNA

SHAPE-Seq 2.0: systematic optimization and extension of high-throughput chemical probing of RNA secondary structure with next generation sequencing

SHAPEwarp-web: sequence-agnostic search for structurally homologous RNA regions across databases of chemical probing data

Web-based platform for analysis of RNA folding from high throughput chemical probing data

Modeling RNA secondary structure folding ensembles using SHAPE mapping data

A pipeline for computational design of novel RNA-like topologies

RNAvigate: efficient exploration of RNA chemical probing datasets

Computational strategies for the automated design of RNA nanoscale structures from building blocks using NanoTiler

Large-Scale in Vitro Transcription, RNA Purification and Chemical Probing Analysis

IPANEMAP: integrative probing analysis of nucleic acids empowered by multiple accessibility profiles

Sequence Design Using RNAstructure

SHAPER: A Web Server for Fast and Accurate SHAPE Reactivity Prediction

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes

Fixed-Parameter Tractable Sampling for RNA Design with Multiple Target Structures

Two-dimensional chemical mapping for non-coding RNAs

Accurate detection of chemical modifications in RNA by mutational profiling (MaP) with ShapeMapper 2

Correcting a SHAPE-directed RNA structure by a mutate-map-rescue approach

RNA Chemical Probing Reagents and Protein Amino Acids: a Double-Edged Sword

Characteristic chemical probing patterns of loop motifs improve prediction accuracy of RNA secondary structures.

Isoform-specific RNA structure determination using Nano-DMS-MaP

A mutate-and-map protocol for inferring base pairs in structured RNA